Similarly, multiple studies have achieved successful CXCR4 gene disruption using CRISPR/Cas9, which conferred resistance to HIV-1 infection in both human and rhesus macaque CD4+ T cells and was associated with reduced viral p24 antigen production [131,132,133,134]. Here, CD4 is linked to HIV-1 infection.